ABSTRACT RULES

1. Abstracts are required for all oral presentations and posters. The Executive Committee will indicate which will be oral presentations and which posters.
2. It is not allowed to submit abstracts of work already published or likely to be published before the Neurodiab 2025 abstract submission deadline and abstracts previously presented at Neurodiab meetings. However, the submission of abstracts presented in recent months at national meetings is accepted.
3. All abstracts should be submitted and presented in clear English with accurate grammar and spelling.
4. Please submit symbols as words.
5. All abbreviations must be defined in the first use.
6. Statements such as «results will be discussed» or «data will be presented» cannot be accepted. For drugs exclusively generic names should be used.
7. It is permitted for a first Author to submit more than 1 abstract. However, presenters that are accepted for oral presentation will be permitted to give only 1 oral presentation. Additional accepted abstracts will therefore be poster only.
8. Abstracts may not be edited/updated after final submission.
9. Your abstract is not successfully submitted until you receive a confirmation e-mail after clicking the final submit button. If you do not receive a confirmation e-mail, please contact [email protected]
10. Presenting author’s contact details (should be the same details [email protected] the submitting author so that the presenting author receives the correspondence about the abstract).
11. Abstract title – in UPPER CASE.
12. Abstract text – limited to 350 words.
13. Abstract layout – Abstracts must be submitted with the following sections: a. Aims | b. Methods | c. Results | d. Conclusions
14. Tables – A maximum of 1 table of up to 10 rows x 10 columns can be included per abstract.
15. Graphs and images – It is important to note that each image included in the abstract is worth 30 words. A maximum of 1 image can be included per abstract.
16. The Abstract Submitter grants the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable non-exclusive basis.
17. The presenting author must register as an active participant at the conference within the early bird registration deadline of 30.06.2025.
18. The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the abstract submission rules.
19. The Executive Committee will review all submitted abstracts, and their decision is final.
20. Deadline of abstract submission: 28.04.2025, midnight CEST time.
21. Notification regarding abstract acceptance and scheduling will be sent to the submitting author by 02.06.2025